ESMO 2026 Presidential Symposia: From Trial Results to Clinical Implications
Phase II Trial Shows Promising Pathologic Responses With Neoadjuvant Nivolumab and Chemotherapy in Salivary Gland Cancer
OncoDaily and Natera Present “Seismic Shift: Innovations in MRD Testing and Pathology”
Sara Tolaney: Breast Cancer Insights From ESMO 2026
High CA-125 Levels: Causes, Normal Range and Cancer Risk
NEOASIS at ESMO 2026: Neoadjuvant Botensilimab Plus Balstilimab in dMMR Colorectal Cancer
A National Multidisciplinary BC Course Has Trained 180 Clinicians Across Mongolia - UICC
ESMO 2026: What’s New in Melanoma Immunotherapy?
The OHSU Knight Cancer Community Symposium 2027, organized by the Knight Cancer Institute at Oregon Health & Science University (OHSU), will take place on April 9, 2027, at the Knight Cancer Research Building in Portland, Oregon, United States, with an online participation option via Webex. This annual symposium will bring together oncologists, hematologists, surgeons, radiation […]
